Increasing operability and survival with intra-aortic ballon pump assist

Area of Science:

• Cardiovascular Surgery
• Mechanical Circulatory Support
• Cardiac Anesthesia

Background:

• High-risk cardiac surgery patients often experience hemodynamic instability.
• Complications like cardiogenic shock and low-output syndrome post-cardiotomy present significant management challenges.
• Intra-aortic balloon pump assist (IABPA) is a critical tool for hemodynamic support.

Purpose of the Study:

• To evaluate the efficacy of Intra-aortic balloon pump assist (IABPA) in a diverse group of high-risk cardiac patients.
• To identify patient subgroups that benefit most from IABPA intervention.
• To assess the impact of IABPA on survival rates in complex cardiac surgical cases.

Main Methods:

• Retrospective analysis of 41 patients managed with IABPA over 12 months.
• Categorization into four groups based on clinical indication for IABPA: post-myocardial infarction shock, postcardiotomy low-output, severe ischemia, and severe left ventricular dysfunction.
• Survival rates were calculated for each group and overall.

Main Results:

• Overall survival rate was 73% across all patient groups.
• Group 1 (post-MI shock): 2/5 survival.
• Group 2 (postcardiotomy low-output): 8/14 survival.
• Group 3 (severe ischemia): 18/19 survival.
• Group 4 (LV dysfunction): 2/3 survival.
• Left ventricular ejection fraction and diastolic pressure time index/tension time index ratio were significant predictors of benefit.

Conclusions:

• IABPA can significantly increase postoperative survival in carefully selected high-risk cardiac surgery patients.
• Early implementation of IABPA, combined with timely angiography and surgical correction, improves outcomes for patients with severe myocardial ischemia and complicated myocardial infarction.
• Left ventricular function parameters are crucial for identifying patients likely to benefit from IABPA therapy.